메뉴 건너뛰기




Volumn 14, Issue 9, 2013, Pages 19257-19275

The consequence of oncomorphic TP53 mutations in ovarian cancer

Author keywords

Chemoresistance; Mutant p53; Oncomorphic mutation; Ovarian cancer; TP53

Indexed keywords

BIOLOGICAL MARKER; DNA; DOXORUBICIN; PACLITAXEL; PROTEIN P53;

EID: 84884585108     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140919257     Document Type: Review
Times cited : (80)

References (127)
  • 2
    • 79959838081 scopus 로고    scopus 로고
    • Integrated genomic analyses of ovarian carcinoma
    • Cancer Genome Atlas Research Network
    • Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011, 474, 609-615.
    • (2011) Nature , vol.474 , pp. 609-615
  • 3
    • 0026337295 scopus 로고
    • Tumor suppressor genes
    • Weinberg, R.A. Tumor suppressor genes. Science 1991, 254, 1138-1146.
    • (1991) Science , vol.254 , pp. 1138-1146
    • Weinberg, R.A.1
  • 4
    • 32144434055 scopus 로고    scopus 로고
    • p53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel-plus platinum-based chemotherapy and long-term clinical outcome
    • Gadducci, A.; di Cristofano, C.; Zavaglia, M.; Giusti, L.; Menicagli, M.; Cosio, S.; Naccarato, A.G.; Genazzani, A.R.; Bevilacqua, G.; Cavazzana, A.O. p53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel-plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res. 2006, 26, 687-693.
    • (2006) Anticancer Res , vol.26 , pp. 687-693
    • Gadducci, A.1    di Cristofano, C.2    Zavaglia, M.3    Giusti, L.4    Menicagli, M.5    Cosio, S.6    Naccarato, A.G.7    Genazzani, A.R.8    Bevilacqua, G.9    Cavazzana, A.O.10
  • 5
    • 0031867659 scopus 로고    scopus 로고
    • Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status
    • Smith-Sorensen, B.; Kaern, J.; Holm, R.; Dorum, A.; Trope, C.; Borresen-Dale, A.L. Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status. Br. J. Cancer 1998, 78, 375-381.
    • (1998) Br. J. Cancer , vol.78 , pp. 375-381
    • Smith-Sorensen, B.1    Kaern, J.2    Holm, R.3    Dorum, A.4    Trope, C.5    Borresen-Dale, A.L.6
  • 6
    • 0027331811 scopus 로고
    • p53 accumulation in ovarian carcinomas and its prognostic implications
    • Bosari, S.; Viale, G.; Radaelli, U.; Bossi, P.; Bonoldi, E.; Coggi, G. p53 accumulation in ovarian carcinomas and its prognostic implications. Hum. Pathol. 1993, 24, 1175-1179.
    • (1993) Hum. Pathol , vol.24 , pp. 1175-1179
    • Bosari, S.1    Viale, G.2    Radaelli, U.3    Bossi, P.4    Bonoldi, E.5    Coggi, G.6
  • 7
    • 0036944970 scopus 로고    scopus 로고
    • Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma
    • Berker, B.; Dunder, I.; Ensari, A.; Cengiz, S.D.; Simsek, E. Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma. Eur. J. Gynaecol. Oncol. 2002, 23, 505-510.
    • (2002) Eur. J. Gynaecol. Oncol , vol.23 , pp. 505-510
    • Berker, B.1    Dunder, I.2    Ensari, A.3    Cengiz, S.D.4    Simsek, E.5
  • 8
    • 0036919875 scopus 로고    scopus 로고
    • Prognostic value of p53 accumulation in epithelial ovarian carcinomas
    • Berker, B.; Dunder, I.; Ensari, A.; Cengiz, S.D. Prognostic value of p53 accumulation in epithelial ovarian carcinomas. Arch. Gynecol. Obstet. 2002, 266, 205-209.
    • (2002) Arch. Gynecol. Obstet , vol.266 , pp. 205-209
    • Berker, B.1    Dunder, I.2    Ensari, A.3    Cengiz, S.D.4
  • 9
    • 0036920077 scopus 로고    scopus 로고
    • Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: A Southwest Oncology Group ancillary study
    • Hawes, D.; Liu, P.Y.; Muggia, F.M.; Wilczynski, S.; Cote, R.; Felix, J.; Terada, K.; Belt, R.J.; Alberts, D.S. Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: A Southwest Oncology Group ancillary study. Gynecol. Oncol. 2002, 87, 17-23.
    • (2002) Gynecol. Oncol , vol.87 , pp. 17-23
    • Hawes, D.1    Liu, P.Y.2    Muggia, F.M.3    Wilczynski, S.4    Cote, R.5    Felix, J.6    Terada, K.7    Belt, R.J.8    Alberts, D.S.9
  • 10
    • 0027945491 scopus 로고
    • Alteration of p53 gene in ovarian carcinoma: Clinicopathological correlation and prognostic significance
    • Niwa, K.; Itoh, M.; Murase, T.; Morishita, S.; Itoh, N.; Mori, H.; Tamaya, T. Alteration of p53 gene in ovarian carcinoma: Clinicopathological correlation and prognostic significance. Br. J. Cancer 1994, 70, 1191-1197.
    • (1994) Br. J. Cancer , vol.70 , pp. 1191-1197
    • Niwa, K.1    Itoh, M.2    Murase, T.3    Morishita, S.4    Itoh, N.5    Mori, H.6    Tamaya, T.7
  • 12
    • 0032077390 scopus 로고    scopus 로고
    • Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer
    • Marx, D.; Meden, H.; Ziemek, T.; Lenthe, T.; Kuhn, W.; Schauer, A. Expression of the p53 tumour suppressor gene as a prognostic marker in platinum-treated patients with ovarian cancer. Eur. J. Cancer 1998, 34, 845-850.
    • (1998) Eur. J. Cancer , vol.34 , pp. 845-850
    • Marx, D.1    Meden, H.2    Ziemek, T.3    Lenthe, T.4    Kuhn, W.5    Schauer, A.6
  • 13
    • 0033883617 scopus 로고    scopus 로고
    • Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy
    • Levesque, M.A.; Katsaros, D.; Massobrio, M.; Genta, F.; Yu, H.; Richiardi, G.; Fracchioli, S.; Durando, A.; Arisio, R.; Diamandis, E.P. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy. Clin. Cancer Res. 2000, 6, 3260-3270.
    • (2000) Clin. Cancer Res , vol.6 , pp. 3260-3270
    • Levesque, M.A.1    Katsaros, D.2    Massobrio, M.3    Genta, F.4    Yu, H.5    Richiardi, G.6    Fracchioli, S.7    Durando, A.8    Arisio, R.9    Diamandis, E.P.10
  • 14
    • 0034332322 scopus 로고    scopus 로고
    • The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma
    • Shahin, M.S.; Hughes, J.H.; Sood, A.K.; Buller, R.E. The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma. Cancer 2000, 89, 2006-2017.
    • (2000) Cancer , vol.89 , pp. 2006-2017
    • Shahin, M.S.1    Hughes, J.H.2    Sood, A.K.3    Buller, R.E.4
  • 15
    • 0030881036 scopus 로고    scopus 로고
    • p53 is a persistent and predictive marker in advanced ovarian carcinomas: Multivariate analysis including comparison with Ki67 immunoreactivity
    • Rohlke, P.; Milde-Langosch, K.; Weyland, C.; Pichlmeier, U.; Jonat, W.; Loning, T. p53 is a persistent and predictive marker in advanced ovarian carcinomas: Multivariate analysis including comparison with Ki67 immunoreactivity. J. Cancer Res. Clin. Oncol. 1997, 123, 496-501.
    • (1997) J. Cancer Res. Clin. Oncol , vol.123 , pp. 496-501
    • Rohlke, P.1    Milde-Langosch, K.2    Weyland, C.3    Pichlmeier, U.4    Jonat, W.5    Loning, T.6
  • 18
    • 0033763955 scopus 로고    scopus 로고
    • p53 mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance
    • Laframboise, S.; Chapman, W.; McLaughlin, J.; Andrulis, I.L. p53 mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance. Cancer J. 2000, 6, 302-308.
    • (2000) Cancer J , vol.6 , pp. 302-308
    • Laframboise, S.1    Chapman, W.2    McLaughlin, J.3    Andrulis, I.L.4
  • 19
    • 0033024368 scopus 로고    scopus 로고
    • Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer
    • Baekelandt, M.; Kristensen, G.B.; Nesland, J.M.; Trope, C.G.; Holm, R. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J. Clin. Oncol. 1999, 17, 2061.
    • (1999) J. Clin. Oncol , vol.17 , pp. 2061
    • Baekelandt, M.1    Kristensen, G.B.2    Nesland, J.M.3    Trope, C.G.4    Holm, R.5
  • 23
    • 0028137423 scopus 로고
    • On the expression of the p53 protein in human cancer
    • Lane, D.P. On the expression of the p53 protein in human cancer. Mol. Biol. Rep. 1994, 19, 23-29.
    • (1994) Mol. Biol. Rep , vol.19 , pp. 23-29
    • Lane, D.P.1
  • 24
    • 15544390722 scopus 로고    scopus 로고
    • Critical evaluation of p53 as a prognostic marker in ovarian cancer
    • Hall, J.; Paul, J.; Brown, R. Critical evaluation of p53 as a prognostic marker in ovarian cancer. Expert. Rev. Mol. Med. 2004, 6, 1-20.
    • (2004) Expert. Rev. Mol. Med , vol.6 , pp. 1-20
    • Hall, J.1    Paul, J.2    Brown, R.3
  • 25
    • 0028299342 scopus 로고
    • p53 in tumour pathology: Can we trust immunohistochemistry?-Revisited!
    • Hall, P.A.; Lane, D.P. p53 in tumour pathology: Can we trust immunohistochemistry?-Revisited! J. Pathol. 1994, 172, 1-4.
    • (1994) J. Pathol , vol.172 , pp. 1-4
    • Hall, P.A.1    Lane, D.P.2
  • 26
    • 0036673758 scopus 로고    scopus 로고
    • Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases
    • Kern, A.; Taubert, H.; Scheele, J.; Rudroff, C.; Mothes, H.; Kappler, M.; Bartel, F.; Richter, K.K. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases. Int. J. Oncol. 2002, 21, 243-249.
    • (2002) Int. J. Oncol , vol.21 , pp. 243-249
    • Kern, A.1    Taubert, H.2    Scheele, J.3    Rudroff, C.4    Mothes, H.5    Kappler, M.6    Bartel, F.7    Richter, K.K.8
  • 27
    • 0027491226 scopus 로고
    • p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas
    • Wadayama, B.; Toguchida, J.; Yamaguchi, T.; Sasaki, M.S.; Yamamuro, T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br. J. Cancer 1993, 68, 1134-1139.
    • (1993) Br. J. Cancer , vol.68 , pp. 1134-1139
    • Wadayama, B.1    Toguchida, J.2    Yamaguchi, T.3    Sasaki, M.S.4    Yamamuro, T.5
  • 28
    • 0028115720 scopus 로고
    • Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer
    • Jolly, K.W.; Malkin, D.; Douglass, E.C.; Brown, T.F.; Sinclair, A.E.; Look, A.T. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 1994, 9, 97-102.
    • (1994) Oncogene , vol.9 , pp. 97-102
    • Jolly, K.W.1    Malkin, D.2    Douglass, E.C.3    Brown, T.F.4    Sinclair, A.E.5    Look, A.T.6
  • 29
    • 0034603728 scopus 로고    scopus 로고
    • p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts
    • Magnusson, K.P.; Sandstrom, M.; Stahlberg, M.; Larsson, M.; Flygare, J.; Hellgren, D.; Wiman, K.G.; Ljungquist, S. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts. Gene 2000, 246, 247-254.
    • (2000) Gene , vol.246 , pp. 247-254
    • Magnusson, K.P.1    Sandstrom, M.2    Stahlberg, M.3    Larsson, M.4    Flygare, J.5    Hellgren, D.6    Wiman, K.G.7    Ljungquist, S.8
  • 30
    • 0034332322 scopus 로고    scopus 로고
    • The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma
    • Shahin, M.S.; Hughes, J.H.; Sood, A.K.; Buller, R.E. The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma. Cancer 2000, 89, 2006-2017.
    • (2000) Cancer , vol.89 , pp. 2006-2017
    • Shahin, M.S.1    Hughes, J.H.2    Sood, A.K.3    Buller, R.E.4
  • 31
    • 0030881036 scopus 로고    scopus 로고
    • p53 is a persistent and predictive marker in advanced ovarian carcinomas: Multivariate analysis including comparison with Ki67 immunoreactivity
    • Rohlke, P.; Milde-Langosch, K.; Weyland, C.; Pichlmeier, U.; Jonat, W.; Loning, T. p53 is a persistent and predictive marker in advanced ovarian carcinomas: Multivariate analysis including comparison with Ki67 immunoreactivity. J. Cancer Res. Clin. Oncol. 1997, 123, 496-501.
    • (1997) J. Cancer Res. Clin. Oncol , vol.123 , pp. 496-501
    • Rohlke, P.1    Milde-Langosch, K.2    Weyland, C.3    Pichlmeier, U.4    Jonat, W.5    Loning, T.6
  • 34
    • 0033763955 scopus 로고    scopus 로고
    • p53 mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance
    • Laframboise, S.; Chapman, W.; McLaughlin, J.; Andrulis, I.L. p53 mutations in epithelial ovarian cancers: Possible role in predicting chemoresistance. Cancer J. 2000, 6, 302-308.
    • (2000) Cancer J , vol.6 , pp. 302-308
    • Laframboise, S.1    Chapman, W.2    McLaughlin, J.3    Andrulis, I.L.4
  • 35
    • 0033024368 scopus 로고    scopus 로고
    • Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer
    • Baekelandt, M.; Kristensen, G.B.; Nesland, J.M.; Trope, C.G.; Holm, R. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. J. Clin. Oncol. 1999, 17, 2061.
    • (1999) J. Clin. Oncol , vol.17 , pp. 2061
    • Baekelandt, M.1    Kristensen, G.B.2    Nesland, J.M.3    Trope, C.G.4    Holm, R.5
  • 39
    • 0028137423 scopus 로고
    • On the expression of the p53 protein in human cancer
    • Lane, D.P. On the expression of the p53 protein in human cancer. Mol. Biol. Rep. 1994, 19, 23-29.
    • (1994) Mol. Biol. Rep , vol.19 , pp. 23-29
    • Lane, D.P.1
  • 40
    • 15544390722 scopus 로고    scopus 로고
    • Critical evaluation of p53 as a prognostic marker in ovarian cancer
    • Hall, J.; Paul, J.; Brown, R. Critical evaluation of p53 as a prognostic marker in ovarian cancer. Expert. Rev. Mol. Med. 2004, 6, 1-20.
    • (2004) Expert. Rev. Mol. Med , vol.6 , pp. 1-20
    • Hall, J.1    Paul, J.2    Brown, R.3
  • 41
    • 0028299342 scopus 로고
    • p53 in tumour pathology: Can we trust immunohistochemistry?-Revisited!
    • Hall, P.A.; Lane, D.P. p53 in tumour pathology: Can we trust immunohistochemistry?-Revisited! J. Pathol. 1994, 172, 1-4.
    • (1994) J. Pathol , vol.172 , pp. 1-4
    • Hall, P.A.1    Lane, D.P.2
  • 42
    • 0036673758 scopus 로고    scopus 로고
    • Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases
    • Kern, A.; Taubert, H.; Scheele, J.; Rudroff, C.; Mothes, H.; Kappler, M.; Bartel, F.; Richter, K.K. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases. Int. J. Oncol. 2002, 21, 243-249.
    • (2002) Int. J. Oncol , vol.21 , pp. 243-249
    • Kern, A.1    Taubert, H.2    Scheele, J.3    Rudroff, C.4    Mothes, H.5    Kappler, M.6    Bartel, F.7    Richter, K.K.8
  • 43
    • 0027491226 scopus 로고
    • p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas
    • Wadayama, B.; Toguchida, J.; Yamaguchi, T.; Sasaki, M.S.; Yamamuro, T. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Br. J. Cancer 1993, 68, 1134-1139.
    • (1993) Br. J. Cancer , vol.68 , pp. 1134-1139
    • Wadayama, B.1    Toguchida, J.2    Yamaguchi, T.3    Sasaki, M.S.4    Yamamuro, T.5
  • 44
    • 0028115720 scopus 로고
    • Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer
    • Jolly, K.W.; Malkin, D.; Douglass, E.C.; Brown, T.F.; Sinclair, A.E.; Look, A.T. Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 1994, 9, 97-102.
    • (1994) Oncogene , vol.9 , pp. 97-102
    • Jolly, K.W.1    Malkin, D.2    Douglass, E.C.3    Brown, T.F.4    Sinclair, A.E.5    Look, A.T.6
  • 45
    • 0034603728 scopus 로고    scopus 로고
    • p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts
    • Int. J. Mol. Sci. 2013, 14 19270
    • Magnusson, K.P.; Sandstrom, M.; Stahlberg, M.; Larsson, M.; Flygare, J.; Hellgren, D.; Wiman, K.G.; Ljungquist, S. p53 splice acceptor site mutation and increased HsRAD51 protein expression in Bloom's syndrome GM1492 fibroblasts. Gene 2000, 246, 247-254. Int. J. Mol. Sci. 2013, 14 19270
    • (2000) Gene , vol.246 , pp. 247-254
    • Magnusson, K.P.1    Sandstrom, M.2    Stahlberg, M.3    Larsson, M.4    Flygare, J.5    Hellgren, D.6    Wiman, K.G.7    Ljungquist, S.8
  • 46
    • 0037209115 scopus 로고    scopus 로고
    • Splice mutations in the p53 gene: Case report and review of the literature
    • Holmila, R.; Fouquet, C.; Cadranel, J.; Zalcman, G.; Soussi, T. Splice mutations in the p53 gene: Case report and review of the literature. Hum. Mutat. 2003, 21, 101-102.
    • (2003) Hum. Mutat , vol.21 , pp. 101-102
    • Holmila, R.1    Fouquet, C.2    Cadranel, J.3    Zalcman, G.4    Soussi, T.5
  • 47
    • 77950517696 scopus 로고    scopus 로고
    • Alternative splicing of p53 and p73: The novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer
    • Hofstetter, G.; Berger, A.; Fiegl, H.; Slade, N.; Zoric, A.; Holzer, B.; Schuster, E.; Mobus, V.J.; Reimer, D.; Daxenbichler, G.; et al. Alternative splicing of p53 and p73: The novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer. Oncogene 2010, 29, 1997-2004.
    • (2010) Oncogene , vol.29 , pp. 1997-2004
    • Hofstetter, G.1    Berger, A.2    Fiegl, H.3    Slade, N.4    Zoric, A.5    Holzer, B.6    Schuster, E.7    Mobus, V.J.8    Reimer, D.9    Daxenbichler, G.10
  • 48
    • 0030021748 scopus 로고    scopus 로고
    • Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant
    • Rowan, S.; Ludwig, R.L.; Haupt, Y.; Bates, S.; Lu, X.; Oren, M.; Vousden, K.H. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J. 1996, 15, 827-838.
    • (1996) EMBO J , vol.15 , pp. 827-838
    • Rowan, S.1    Ludwig, R.L.2    Haupt, Y.3    Bates, S.4    Lu, X.5    Oren, M.6    Vousden, K.H.7
  • 49
    • 84884585971 scopus 로고    scopus 로고
    • Available online, (accessed on 3 January 2013)
    • IARC TP53 Database R16 Version. Available online: http://p53.iarc.fr/ (accessed on 3 January 2013).
    • IARC TP53 Database R16 Version
  • 50
    • 34248379012 scopus 로고    scopus 로고
    • Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database
    • Petitjean, A.M.E.; Kato, S.; Ishioka, C.; Tavtigian, S.V.; Hainaut, P.; Olivier, M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum. Mutat. 2007, 28, 622-629.
    • (2007) Hum. Mutat , vol.28 , pp. 622-629
    • Petitjean, A.M.E.1    Kato, S.2    Ishioka, C.3    Tavtigian, S.V.4    Hainaut, P.5    Olivier, M.6
  • 53
    • 2542424899 scopus 로고    scopus 로고
    • Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line
    • Chan, K.T.; Lung, M.L. Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line. Cancer Chemother. Pharmacol. 2004, 53, 519-526.
    • (2004) Cancer Chemother. Pharmacol , vol.53 , pp. 519-526
    • Chan, K.T.1    Lung, M.L.2
  • 54
    • 0034671945 scopus 로고    scopus 로고
    • Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome
    • Sigal, A.; Rotter, V. Oncogenic mutations of the p53 tumor suppressor: The demons of the guardian of the genome. Cancer Res. 2000, 60, 6788-6793.
    • (2000) Cancer Res , vol.60 , pp. 6788-6793
    • Sigal, A.1    Rotter, V.2
  • 56
    • 0033552948 scopus 로고    scopus 로고
    • Mutant p53 gain of function: Differential effects of different p53 mutants on resistance of cultured cells to chemotherapy
    • Blandino, G.; Levine, A.J.; Oren, M. Mutant p53 gain of function: Differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 1999, 18, 477-485.
    • (1999) Oncogene , vol.18 , pp. 477-485
    • Blandino, G.1    Levine, A.J.2    Oren, M.3
  • 57
    • 0034978219 scopus 로고    scopus 로고
    • Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells
    • Chang, F.L.; Lai, M.D. Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells. J. Urol. 2001, 166, 304-310.
    • (2001) J. Urol , vol.166 , pp. 304-310
    • Chang, F.L.1    Lai, M.D.2
  • 59
    • 77149146794 scopus 로고    scopus 로고
    • A common gain of function of p53 cancer mutants in inducing genetic instability
    • Liu, D.P.; Song, H.; Xu, Y. A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 2010, 29, 949-956.
    • (2010) Oncogene , vol.29 , pp. 949-956
    • Liu, D.P.1    Song, H.2    Xu, Y.3
  • 60
    • 0036260527 scopus 로고    scopus 로고
    • Does p53 affect organismal aging?
    • Donehower, L.A. Does p53 affect organismal aging? J. Cell. Physiol. 2002, 192, 23-33.
    • (2002) J. Cell. Physiol , vol.192 , pp. 23-33
    • Donehower, L.A.1
  • 62
    • 46749158345 scopus 로고    scopus 로고
    • The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo
    • Lee, M.K.; Sabapathy, K. The R246S hot-spot p53 mutant exerts dominant-negative effects in embryonic stem cells in vitro and in vivo. J. Cell. Sci. 2008, 121, 1899-1906.
    • (2008) J. Cell. Sci , vol.121 , pp. 1899-1906
    • Lee, M.K.1    Sabapathy, K.2
  • 63
    • 77956069027 scopus 로고    scopus 로고
    • Mouse models of p53 functions
    • doi:10.1101/cshperspect.a001115
    • Lozano, G. Mouse models of p53 functions. Cold Spring Harb. Perspect. Biol. 2010, 2, doi:10.1101/cshperspect.a001115.
    • (2010) Cold Spring Harb. Perspect. Biol , vol.2
    • Lozano, G.1
  • 64
    • 70350567735 scopus 로고    scopus 로고
    • 20 years studying p53 functions in genetically engineered mice
    • Donehower, L.A.; Lozano, G. 20 years studying p53 functions in genetically engineered mice. Nat. Rev. Cancer 2009, 9, 831-841.
    • (2009) Nat. Rev. Cancer , vol.9 , pp. 831-841
    • Donehower, L.A.1    Lozano, G.2
  • 66
    • 84862636275 scopus 로고    scopus 로고
    • Mutant p53: One name, many proteins
    • Freed-Pastor, W.A.; Prives, C. Mutant p53: One name, many proteins. Genes Dev. 2012, 26, 1268-1286.
    • (2012) Genes Dev , vol.26 , pp. 1268-1286
    • Freed-Pastor, W.A.1    Prives, C.2
  • 67
    • 0031834336 scopus 로고    scopus 로고
    • Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain
    • Frazier, M.W.; He, X.; Wang, J.; Gu, Z.; Cleveland, J.L.; Zambetti, G.P. Activation of c-myc gene expression by tumor-derived p53 mutants requires a discrete C-terminal domain. Mol. Cell. Biol. 1998, 18, 3735-3743.
    • (1998) Mol. Cell. Biol , vol.18 , pp. 3735-3743
    • Frazier, M.W.1    He, X.2    Wang, J.3    Gu, Z.4    Cleveland, J.L.5    Zambetti, G.P.6
  • 68
    • 66449112610 scopus 로고    scopus 로고
    • Identification of GRO1 as a critical determinant for mutant p53 gain of function
    • Yan, W.; Chen, X. Identification of GRO1 as a critical determinant for mutant p53 gain of function. J. Biol. Chem. 2009, 284, 12178-12187.
    • (2009) J. Biol. Chem , vol.284 , pp. 12178-12187
    • Yan, W.1    Chen, X.2
  • 70
    • 77951982002 scopus 로고    scopus 로고
    • Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function
    • Gurtner, A.; Starace, G.; Norelli, G.; Piaggio, G.; Sacchi, A.; Bossi, G. Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function. J. Biol. Chem. 2010, 285, 14160-14169.
    • (2010) J. Biol. Chem , vol.285 , pp. 14160-14169
    • Gurtner, A.1    Starace, G.2    Norelli, G.3    Piaggio, G.4    Sacchi, A.5    Bossi, G.6
  • 71
    • 0033813790 scopus 로고    scopus 로고
    • Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation
    • Preuss, U.; Kreutzfeld, R.; Scheidtmann, K.H. Tumor-derived p53 mutant C174Y is a gain-of-function mutant which activates the fos promoter and enhances colony formation. Int. J. Cancer 2000, 88, 162-171.
    • (2000) Int. J. Cancer , vol.88 , pp. 162-171
    • Preuss, U.1    Kreutzfeld, R.2    Scheidtmann, K.H.3
  • 72
    • 0026733710 scopus 로고
    • Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells
    • Deb, S.; Jackson, C.T.; Subler, M.A.; Martin, D.W. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells. J. Virol. 1992, 66, 6164-6170.
    • (1992) J. Virol , vol.66 , pp. 6164-6170
    • Deb, S.1    Jackson, C.T.2    Subler, M.A.3    Martin, D.W.4
  • 73
    • 33748211158 scopus 로고    scopus 로고
    • Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
    • Di Agostino, S.; Strano, S.; Emiliozzi, V.; Zerbini, V.; Mottolese, M.; Sacchi, A.; Blandino, G.; Piaggio, G. Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 2006, 10, 191-202.
    • (2006) Cancer Cell , vol.10 , pp. 191-202
    • Di Agostino, S.1    Strano, S.2    Emiliozzi, V.3    Zerbini, V.4    Mottolese, M.5    Sacchi, A.6    Blandino, G.7    Piaggio, G.8
  • 75
    • 79959840762 scopus 로고    scopus 로고
    • Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance
    • Sankala, H.; Vaughan, C.; Wang, J.; Deb, S.; Graves, P.R. Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance. Arch. Biochem. Biophys. 2011, 512, 52-60.
    • (2011) Arch. Biochem. Biophys , vol.512 , pp. 52-60
    • Sankala, H.1    Vaughan, C.2    Wang, J.3    Deb, S.4    Graves, P.R.5
  • 80
    • 83255185781 scopus 로고    scopus 로고
    • TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73
    • Liu, K.; Ling, S.; Lin, W.C. TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73. Mol. Cell. Biol. 2011, 31, 4464-4481.
    • (2011) Mol. Cell. Biol , vol.31 , pp. 4464-4481
    • Liu, K.1    Ling, S.2    Lin, W.C.3
  • 81
    • 0035131701 scopus 로고    scopus 로고
    • A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
    • Gaiddon, C.; Lokshin, M.; Ahn, J.; Zhang, T.; Prives, C. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol. Cell. Biol. 2001, 21, 1874-1887.
    • (2001) Mol. Cell. Biol , vol.21 , pp. 1874-1887
    • Gaiddon, C.1    Lokshin, M.2    Ahn, J.3    Zhang, T.4    Prives, C.5
  • 83
    • 0032951530 scopus 로고    scopus 로고
    • p73 function is inhibited by tumor-derived p53 mutants in mammalian cells
    • Di Como, C.J.; Gaiddon, C.; Prives, C. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol. 1999, 19, 1438-1449.
    • (1999) Mol. Cell. Biol , vol.19 , pp. 1438-1449
    • di Como, C.J.1    Gaiddon, C.2    Prives, C.3
  • 85
    • 0031264285 scopus 로고    scopus 로고
    • p53 represses Sp1 DNA binding and HIV-LTR directed transcription
    • Bargonetti, J.; Chicas, A.; White, D.; Prives, C. p53 represses Sp1 DNA binding and HIV-LTR directed transcription. Cell. Mol. Biol. 1997, 43, 935-949.
    • (1997) Cell. Mol. Biol , vol.43 , pp. 935-949
    • Bargonetti, J.1    Chicas, A.2    White, D.3    Prives, C.4
  • 87
    • 0035264636 scopus 로고    scopus 로고
    • Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C
    • Torgeman, A.; Mor-Vaknin, N.; Zelin, E.; Ben-Aroya, Z.; Lochelt, M.; Flugel, R.M.; Aboud, M. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 2001, 281, 10-20.
    • (2001) Virology , vol.281 , pp. 10-20
    • Torgeman, A.1    Mor-Vaknin, N.2    Zelin, E.3    Ben-Aroya, Z.4    Lochelt, M.5    Flugel, R.M.6    Aboud, M.7
  • 88
    • 81855225839 scopus 로고    scopus 로고
    • MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF
    • Hwang, C.I.; Choi, J.; Zhou, Z.; Flesken-Nikitin, A.; Tarakhovsky, A.; Nikitin, A.Y. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Cell Cycle 2011, 10, 3834-3840.
    • (2011) Cell Cycle , vol.10 , pp. 3834-3840
    • Hwang, C.I.1    Choi, J.2    Zhou, Z.3    Flesken-Nikitin, A.4    Tarakhovsky, A.5    Nikitin, A.Y.6
  • 89
    • 34247329362 scopus 로고    scopus 로고
    • p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
    • Song, H.; Hollstein, M.; Xu, Y. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat. Cell. Biol. 2007, 9, 573-580.
    • (2007) Nat. Cell. Biol , vol.9 , pp. 573-580
    • Song, H.1    Hollstein, M.2    Xu, Y.3
  • 91
    • 0032914810 scopus 로고    scopus 로고
    • Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancer
    • Wong, A.S.; Maines-Bandiera, S.L.; Rosen, B.; Wheelock, M.J.; Johnson, K.R.; Leung, P.C.; Roskelley, C.D.; Auersperg, N. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancer. Int. J. Cancer 1999, 81, 180-188.
    • (1999) Int. J. Cancer , vol.81 , pp. 180-188
    • Wong, A.S.1    Maines-Bandiera, S.L.2    Rosen, B.3    Wheelock, M.J.4    Johnson, K.R.5    Leung, P.C.6    Roskelley, C.D.7    Auersperg, N.8
  • 95
  • 96
    • 0032574788 scopus 로고    scopus 로고
    • An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
    • Gualberto, A.; Aldape, K.; Kozakiewicz, K.; Tlsty, T.D. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. USA 1998, 95, 5166-5171.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 5166-5171
    • Gualberto, A.1    Aldape, K.2    Kozakiewicz, K.3    Tlsty, T.D.4
  • 101
    • 84880302677 scopus 로고    scopus 로고
    • Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
    • Hanel, W.; Marchenko, N.; Xu, S.; Yu, S.X.; Weng, W.; Moll, U. Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ. 2013, 20, 898-909.
    • (2013) Cell Death Differ , vol.20 , pp. 898-909
    • Hanel, W.1    Marchenko, N.2    Xu, S.3    Yu, S.X.4    Weng, W.5    Moll, U.6
  • 102
    • 0029757120 scopus 로고    scopus 로고
    • Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene
    • Werner, H.; Karnieli, E.; Rauscher, F.J.; LeRoith, D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA 1996, 93, 8318-8323.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 8318-8323
    • Werner, H.1    Karnieli, E.2    Rauscher, F.J.3    LeRoith, D.4
  • 106
    • 0031789426 scopus 로고    scopus 로고
    • Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53172H mutant and p53-knockout mice after chemical carcinogenesis: Evidence for a gain of function
    • Wang, X.J.; Greenhalgh, D.A.; Jiang, A.; He, D.; Zhong, L.; Brinkley, B.R.; Roop, D.R. Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53172H mutant and p53-knockout mice after chemical carcinogenesis: Evidence for a gain of function. Mol. Carcinog. 1998, 23, 185-192.
    • (1998) Mol. Carcinog , vol.23 , pp. 185-192
    • Wang, X.J.1    Greenhalgh, D.A.2    Jiang, A.3    He, D.4    Zhong, L.5    Brinkley, B.R.6    Roop, D.R.7
  • 107
    • 84873732369 scopus 로고    scopus 로고
    • Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53
    • Meng, X.; Laidler, L.L.; Kosmacek, E.A.; Yang, S.; Xiong, Z.; Zhu, D.; Wang, X.; Dai, D.; Zhang, Y.; Wang, X.; et al. Induction of mitotic cell death by overriding G2/M checkpoint in endometrial cancer cells with non-functional p53. Gynecol. Oncol. 2012, 128, 461-469.
    • (2012) Gynecol. Oncol , vol.128 , pp. 461-469
    • Meng, X.1    Laidler, L.L.2    Kosmacek, E.A.3    Yang, S.4    Xiong, Z.5    Zhu, D.6    Wang, X.7    Dai, D.8    Zhang, Y.9    Wang, X.10
  • 108
    • 71049146802 scopus 로고    scopus 로고
    • Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway
    • Dong, P.; Xu, Z.; Jia, N.; Li, D.; Feng, Y. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway. Mol. Cancer 2009, 8, 103.
    • (2009) Mol. Cancer , vol.8 , pp. 103
    • Dong, P.1    Xu, Z.2    Jia, N.3    Li, D.4    Feng, Y.5
  • 109
    • 77952005099 scopus 로고    scopus 로고
    • Characterization of functional domains necessary for mutant p53 gain of function
    • Yan, W.; Chen, X. Characterization of functional domains necessary for mutant p53 gain of function. J. Biol. Chem. 2010, 285, 14229-14238.
    • (2010) J. Biol. Chem , vol.285 , pp. 14229-14238
    • Yan, W.1    Chen, X.2
  • 110
    • 0026555717 scopus 로고
    • Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
    • Chin, K.V.; Ueda, K.; Pastan, I.; Gottesman, M.M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992, 255, 459-462.
    • (1992) Science , vol.255 , pp. 459-462
    • Chin, K.V.1    Ueda, K.2    Pastan, I.3    Gottesman, M.M.4
  • 111
    • 0029062595 scopus 로고
    • Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants
    • Lin, J.; Teresky, A.K.; Levine, A.J. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene 1995, 10, 2387-2390.
    • (1995) Oncogene , vol.10 , pp. 2387-2390
    • Lin, J.1    Teresky, A.K.2    Levine, A.J.3
  • 112
    • 34548770025 scopus 로고    scopus 로고
    • Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis
    • Singer, S.; Ehemann, V.; Brauckhoff, A.; Keith, M.; Vreden, S.; Schirmacher, P.; Breuhahn, K. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. Hepatology 2007, 46, 759-768.
    • (2007) Hepatology , vol.46 , pp. 759-768
    • Singer, S.1    Ehemann, V.2    Brauckhoff, A.3    Keith, M.4    Vreden, S.5    Schirmacher, P.6    Breuhahn, K.7
  • 113
    • 33750036093 scopus 로고    scopus 로고
    • Structural basis for understanding oncogenic p53 mutations and designing rescue drugs
    • Joerger, A.C.; Ang, H.C.; Fersht, A.R. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc. Natl. Acad. Sci. USA 2006, 103, 15056-15061.
    • (2006) Proc. Natl. Acad. Sci. USA , vol.103 , pp. 15056-15061
    • Joerger, A.C.1    Ang, H.C.2    Fersht, A.R.3
  • 115
    • 0031680722 scopus 로고    scopus 로고
    • Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer
    • Suzuki, M.; Saito, S.; Saga, Y.; Ohwada, M.; Sato, I. Loss of heterozygosity on chromosome 6q27 and p53 mutations in epithelial ovarian cancer. Med. Oncol. 1998, 15, 119-123.
    • (1998) Med. Oncol , vol.15 , pp. 119-123
    • Suzuki, M.1    Saito, S.2    Saga, Y.3    Ohwada, M.4    Sato, I.5
  • 117
    • 33845611951 scopus 로고    scopus 로고
    • Modeling the therapeutic efficacy of p53 restoration in tumors
    • Martins, C.P.; Brown-Swigart, L.; Evan, G.I. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006, 127, 1323-1334.
    • (2006) Cell , vol.127 , pp. 1323-1334
    • Martins, C.P.1    Brown-Swigart, L.2    Evan, G.I.3
  • 122
    • 15844363948 scopus 로고    scopus 로고
    • Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell
    • Sepehrnia, B.; Paz, I.B.; Dasgupta, G.; Momand, J. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J. Biol. Chem. 1996, 271, 15084-15090.
    • (1996) J. Biol. Chem , vol.271 , pp. 15084-15090
    • Sepehrnia, B.1    Paz, I.B.2    Dasgupta, G.3    Momand, J.4
  • 123
    • 0029737509 scopus 로고    scopus 로고
    • Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90
    • Blagosklonny, M.V.; Toretsky, J.; Bohen, S.; Neckers, L. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc. Natl. Acad. Sci. USA 1996, 93, 8379-8383.
    • (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 8379-8383
    • Blagosklonny, M.V.1    Toretsky, J.2    Bohen, S.3    Neckers, L.4
  • 124
    • 0035794143 scopus 로고    scopus 로고
    • Stabilization of the MDM2 oncoprotein by mutant p53
    • Peng, Y.; Chen, L.; Li, C.; Lu, W.; Agrawal, S.; Chen, J. Stabilization of the MDM2 oncoprotein by mutant p53. J. Biol. Chem. 2001, 276, 6874-6878.
    • (2001) J. Biol. Chem , vol.276 , pp. 6874-6878
    • Peng, Y.1    Chen, L.2    Li, C.3    Lu, W.4    Agrawal, S.5    Chen, J.6
  • 125
    • 0035798547 scopus 로고    scopus 로고
    • Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization
    • Peng, Y.; Chen, L.; Li, C.; Lu, W.; Chen, J. Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization. J. Biol. Chem. 2001, 276, 40583-40590.
    • (2001) J. Biol. Chem , vol.276 , pp. 40583-40590
    • Peng, Y.1    Chen, L.2    Li, C.3    Lu, W.4    Chen, J.5
  • 126
    • 81155134638 scopus 로고    scopus 로고
    • SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
    • Li, D.; Marchenko, N.D.; Moll, U.M. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis. Cell Death Differ. 2011, 18, 1904-1913.
    • (2011) Cell Death Differ , vol.18 , pp. 1904-1913
    • Li, D.1    Marchenko, N.D.2    Moll, U.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.